CORT

Corcept Therapeutics Incorporated

Stock

$116.23+2.20 (+1.93%)Close Oct 2, 2026

Shareholders' equity

Period	On	Equity	YoY	Filing
2025	Dec 31, 2025	$648M	−4.7%	10-K, Feb 24, 2026
2024	Dec 31, 2024	$680M	+34.1%	10-K, Feb 26, 2025
2023	Dec 31, 2023	$507M	+1.0%	10-K, Feb 15, 2024
2022	Dec 31, 2022	$502M	+33.5%	10-K, Feb 28, 2023
2021	Dec 31, 2021	$376M	−28.2%	10-K, Feb 15, 2022
2020	Dec 31, 2020	$523M	+41.0%	10-K, Feb 23, 2021
2019	Dec 31, 2019	$371M	+34.5%	10-K, Feb 24, 2020
2018	Dec 31, 2018	$276M	+44.5%	10-K, Feb 26, 2019
2017	Dec 31, 2017	$191M	+361.5%	10-K, Feb 28, 2018
2016	Dec 31, 2016	$41M	+123.7%	10-K, Mar 6, 2017
2015	Dec 31, 2015	$18M	—	10-K, Mar 10, 2016
2014	Dec 31, 2014	−$3.4M	—	10-K, Mar 13, 2015
2013	Dec 31, 2013	$21M	−66.0%	10-K, Mar 14, 2014
2012	Dec 31, 2012	$62M	+77.5%	10-K, Mar 15, 2013
2011	Dec 31, 2011	$35M	+63.8%	10-K, Mar 13, 2012
2010	Dec 31, 2010	$21M	−3.8%	10-K, Mar 13, 2012
2009	Dec 31, 2009	$22M	+30.7%	10-K, Mar 13, 2012
2008	Dec 31, 2008	$17M	+14.7%	10-K, Mar 13, 2012
2007	Dec 31, 2007	$15M	+131.7%	10-K, Mar 13, 2012
2006	Dec 31, 2006	$6.4M	−76.1%	10-K, Mar 13, 2012
2005	Dec 31, 2005	$27M	−42.1%	10-K, Mar 13, 2012
2004	Dec 31, 2004	$46M	—	10-K, Mar 13, 2012
2003	Dec 31, 2003	−$31M	—	10-K, Mar 13, 2012
2002	Dec 31, 2002	−$22M	—	10-K, Mar 13, 2012
2001	Dec 31, 2001	−$7.5M	—	10-K, Mar 13, 2012
2000	Dec 31, 2000	−$2.0M	—	10-K, Mar 13, 2012